Literature DB >> 10458335

Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy.

T G Cangiano1, M S Litwin, J Naitoh, F Dorey, J B deKernion.   

Abstract

PURPOSE: We describe the clinical and pathological outcomes of intraoperative frozen sections performed on the posterolateral prostate margins during nerve sparing radical prostatectomy.
MATERIALS AND METHODS: We developed a technique of bilateral nerve sparing, inking the posterolateral prostate margins and obtaining frozen sections. When tumor was seen on frozen section, the fascia and neurovascular bundle were widely excised before completing the vesicourethral anastomosis. We reviewed 142 radical retropubic prostatectomies performed by a single surgeon between 1992 and 1997. Patients were divided into group 1--nerve sparing procedure using our technique (48 patients), 2--planned unilateral nerve sparing without frozen sections (46) and 3--planned bilateral nerve sparing without frozen sections (48). Potency was measured implicitly by physician assessment and explicitly with the UCLA Prostate Cancer Index. Group comparisons were made for positive margins, biochemical recurrence and potency. Mean followup was 24.5, 43.8 and 39.4 months for groups 1, 2 and 3, respectively.
RESULTS: Of the 48 group 1 patients 9 (18%) had adenocarcinoma in the frozen section specimen, prompting wide excision of the bundles. None of these patients had biochemical recurrence during a mean followup of 20.5 months. Both bundles were spared in the remaining 39 patients (82%). There was no difference in survival or time to biochemical recurrence between groups 1 and 2. Potency was significantly different between groups 1 and 2 (36 versus 13%, p = 0.001), even after age adjustment (p = 0.05). In contrast, potency did not differ between groups 1 and 3 (38 versus 40%). Preoperative stage, grade and prostate specific antigen level were similar among the 3 groups.
CONCLUSIONS: We found a significant difference in potency rates adjusted for age between patients with and without frozen sections. Our results indicate that this technique can enhance the ability of the surgeon to monitor the nerve sparing procedure without compromising cancer control.

Entities:  

Mesh:

Year:  1999        PMID: 10458335     DOI: 10.1097/00005392-199909010-00003

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  [Technique of nerve-sparing radical retropubic prostatectomy].

Authors:  M Graefen; H Huland
Journal:  Urologe A       Date:  2004-02       Impact factor: 0.639

2.  Macrocryosectioning and complete sampling of the prostate in a potential multiorgan donor candidate.

Authors:  Roberta Mazzucchelli; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

Review 3.  Value of frozen section biopsies during radical prostatectomy: significance of the histological results.

Authors:  Miguel Ramírez-Backhaus; Robert Rabenalt; Sunjay Jain; Minh Do; Evangelos Liatsikos; Roman Ganzer; Lars-Christian Horn; Martin Burchardt; Fernando Jiménez-Cruz; Jens-Uwe Stolzenburg
Journal:  World J Urol       Date:  2008-12-10       Impact factor: 4.226

4.  Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer.

Authors:  Andreas Becker; Carolina Coelius; Meike Adam; Pierre Tennstedt; Luis Kluth; Thomas Steuber; Hans Heinzer; Markus Graefen; Thorsten Schlomm; Uwe Michl
Journal:  World J Urol       Date:  2014-03-26       Impact factor: 4.226

5.  Clinical impact of intraoperative frozen sections during nerve-sparing radical prostatectomy.

Authors:  Elmar Heinrich; Georg Schön; Frank Schiefelbein; Maurice Stephan Michel; Lutz Trojan
Journal:  World J Urol       Date:  2010-04-01       Impact factor: 4.226

6.  Practice Patterns of Korean Urologists Regarding Positive Surgical Margins after Radical Prostatectomy: a Survey and Narrative Review.

Authors:  Jae Hyun Ryu; Yun Beom Kim; Tae Young Jung; Woo Jin Ko; Sun Il Kim; Dongdeuk Kwon; Duk Yoon Kim; Tae Hee Oh; Tag Keun Yoo
Journal:  J Korean Med Sci       Date:  2021-10-25       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.